Cargando…
BT-09 CLINICAL AND MOLECULAR GENETIC FEATURE OF CEREBELLAR GLIOBLASTOMA
INTRODUCTION: Cerebellar glioblastoma (cGBM) is extremely rare, accounting for 0.7–0.9% of all gliomas. Few studies have reported on clinical course, histopathology, and prognosis. In this report, we discussed cases which were diagnosed as cGBM, and were treated in our institute. MATERIALS AND METHO...
Autores principales: | Iijima, Shohei, Saito, Kuniaki, Shimizu, Saki, Kobayashi, Keiichi, Shimada, Daisuke, Matsumoto, Yoshie, Shiokawa, Yoshiaki, Nagane, Motoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213448/ http://dx.doi.org/10.1093/noajnl/vdz039.170 |
Ejemplares similares
-
COT-20 PERIOPERATIVE STATUS OF SERUM D-DIMER LEVEL AND VENOUS THROMBOSIS IN PATIENTS WITH MALIGNANT BRAIN TUMOR
por: Shimada, Daisuke, et al.
Publicado: (2019) -
STMO-18 SUBPIAL RESECTION OF GLIOMA USING CUSA CLARITY
por: Saito, Kuniaki, et al.
Publicado: (2019) -
STMO-09 Recovery from speech deficit after injury to frontal aslant tract in glioma surgery
por: Saito, Kuniaki, et al.
Publicado: (2020) -
ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma
por: Nagane, Motoo, et al.
Publicado: (2020) -
STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
por: Kobayashi, Keiichi, et al.
Publicado: (2019)